Skip to content

Standardized Diagnosis and Treatment of Immunocompromised Host Pneumonia and the Establishment of Clinical Pathways

Standardized Diagnosis and Treatment of Immunocompromised Host Pneumonia and the Establishment of Clinical Pathways

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123167
Enrollment
Unknown
Registered
2026-04-22
Start date
2025-08-02
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immuno-compromised host pneumonia

Interventions

Clinical pathway group:A multidisciplinary team (MDT) develops and executes a standardized clinical pathway, covering six key steps and 24 criteria, to optimize the diagnosis and treatment process, im
Conventional strategy group:Following the existing conventional diagnosis and treatment mode of the hospital, there is no unified path constraint, reflecting the current non-standardized treatment sta

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of ICHP and the definition standards for immunocompromised populations; 2. Patients aged 18 years or older; 3. Patients with clear consciousness who can communicate normally and cooperate in completing relevant scale questionnaires; 4. Patients who have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients requiring tracheal intubation or direct admission to the intensive care unit; 2. Yulnerable groups, including persons with mental illness, persons with cognitive impairment, pregnant or breastfeeding women; 3. Alcohol addicts; 4. Patients with renal failure (estimated creatinine clearance <20 mL/min); 5. The investigator considers that there is any situation that may affect the test results, interrupt the test process (or the subject is unable to complete all the required operations and visits).

Design outcomes

Primary

MeasureTime frame
clinical remission rate;

Secondary

MeasureTime frame
The direct cost of resource consumption;Short form-36 physical component score (SF-36 PCS) differences;Adverse events involving permanent or severe disability or loss of function;

Countries

China

Contacts

Public ContactJu Chunrong

The Datansha Campus of the First Affiliated Hospital of Guangzhou Medical University

juchunrong@gzhmu.edu.cn+86 159 1576 1346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026